Portable device paves way for better detection of foodborne illness

Portable device paves way for better detection of foodborne illness

Foodborne illness hits about one in six people in the United States every year. The Centers for Disease Control and Prevention estimates that 48 million people in the U.S. get sick due to one or more of 31 recognized pathogens, including E. coli O157:H7, a particularly harsh strain of E. coli. Researchers at Purdue University have been working to develop new technologies to help stop the spread of foodborne illnesses, which kill 3,000 people a year, by detecting them more efficiently. They have developed a bioluminescence-based assay coupled with a portable device that works with smartphones and laptops to do on-site testing for harmful E. coli in food samples. The silicon photomultiplier (SiPM) device uses low light to from the bioluminescent assay to detect the presence of bacteria that cause foodborne illness in food samples. The Purdue team also created an electrical circuit with an amplifier, comparator and microcontroller to send the data to laptops and smartphones via Bluetooth technology. They used 3D printing to design a portable cradle for the SiPM. The research is published in the January edition of Applied Optics . Our goal is to create technology and a process that allows for the cost-effective detection of the causes of foodborne illness using an easy, expedient and efficient process." Euiwon Bae, senior research scientist of mechanical engineering in Purdue's College of Engineering Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More